(Q38959172)

English

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort.

scientific article published on 19 September 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

0 references

0 references

head and neck squamous cell carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Tanguy Y Seiwert

22

object named as

Tanguy Y Seiwert

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Laura Q M Chow

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Robert Haddad

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Shilpa Gupta

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Ranee Mehra

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Makoto Tahara

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Raanan Berger

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Joseph Paul Eder

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Barbara Burtness

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Se-Hoon Lee

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Bhumsuk Keam

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Kei Muro

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jared Weiss

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Ravit Geva

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Chia-Chi Lin

16

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Hyun Cheol Chung

17

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Amy Meister

18

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Marisa Dolled-Filhart

19

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Kumudu Pathiraja

20

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jonathan D Cheng

21

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

language of work or name

0 references

publication date

30 September 2016

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

34

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

32

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

3838-3845

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Comprehensive genomic characterization of head and neck squamous cell carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PD-1 and its ligands in tolerance and immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Base

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of recurrent metastatic head and neck cancer: focus on cetuximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promising systemic immunotherapies in head and neck squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platinum-based chemotherapy plus cetuximab in head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pembrolizumab for the treatment of non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human papillomavirus and survival of patients with oropharyngeal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Cancer Society Head and Neck Cancer Survivorship Care Guideline

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of p16 in Site-specific HPV Positive and HPV Negative Head and Neck Squamous Cell Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The blockade of immune checkpoints in cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pembrolizumab versus Ipilimumab in Advanced Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy for head and neck squamous cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27646946

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2016.68.1478

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27646946%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38959172&oldid=1516757594"